Mitem Pharma
Paris, France· Est.
Develops small molecule therapeutics targeting mitochondrial dysfunction for metabolic and neurodegenerative diseases.
Private Company
Total funding raised: $5M
About
Develops small molecule therapeutics targeting mitochondrial dysfunction for metabolic and neurodegenerative diseases.
Generic Drugs
Funding History
1Total raised:$5M
Seed$5M
FDA Approved Drugs
1DESFERALNDAApr 1, 1968